These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23243634)

  • 1. Remestemcel-L, the first cellular therapy product for the treatment of graft-versus-host disease.
    Daly A
    Drugs Today (Barc); 2012 Dec; 48(12):773-83. PubMed ID: 23243634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remestemcel-L for the treatment of graft versus host disease.
    Locatelli F; Algeri M; Trevisan V; Bertaina A
    Expert Rev Clin Immunol; 2017 Jan; 13(1):43-56. PubMed ID: 27399600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stromal cells for graft-versus-host disease.
    Tolar J; Villeneuve P; Keating A
    Hum Gene Ther; 2011 Mar; 22(3):257-62. PubMed ID: 21288086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Steroid-Refractory Acute Graft-
    Murata M; Teshima T
    Front Immunol; 2021; 12():724380. PubMed ID: 34489977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease.
    Kurtzberg J; Abdel-Azim H; Carpenter P; Chaudhury S; Horn B; Mahadeo K; Nemecek E; Neudorf S; Prasad V; Prockop S; Quigg T; Satwani P; Cheng A; Burke E; Hayes J; Skerrett D;
    Biol Blood Marrow Transplant; 2020 May; 26(5):845-854. PubMed ID: 32018062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Follow-Up After the Application of Mesenchymal Stromal Cells in Children and Adolescents with Steroid-Refractory Graft-Versus-Host Disease.
    Döring M; Cabanillas Stanchi KM; Lenglinger K; Treuner C; Gieseke F; Erbacher A; Mezger M; Vaegler M; Schlegel PG; Greil J; Bettoni da Cunha Riehm C; Faul C; Schumm M; Lang P; Handgretinger R; Müller I
    Stem Cells Dev; 2021 Mar; 30(5):234-246. PubMed ID: 33446053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Chen X; Wang C; Yin J; Xu J; Wei J; Zhang Y
    PLoS One; 2015; 10(8):e0136991. PubMed ID: 26323092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease.
    Kebriaei P; Hayes J; Daly A; Uberti J; Marks DI; Soiffer R; Waller EK; Burke E; Skerrett D; Shpall E; Martin PJ
    Biol Blood Marrow Transplant; 2020 May; 26(5):835-844. PubMed ID: 31505228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the Evidence.
    Rizk M; Monaghan M; Shorr R; Kekre N; Bredeson CN; Allan DS
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1416-1423. PubMed ID: 27130504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells targeting the GVHD.
    Wang L; Zhao RC
    Sci China C Life Sci; 2009 Jul; 52(7):603-9. PubMed ID: 19641864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells for steroid-refractory acute graft-versus-host disease: a report of two cases.
    Lim JH; Lee MH; Yi HG; Kim CS; Kim JH; Song SU
    Int J Hematol; 2010 Jul; 92(1):204-7. PubMed ID: 20514533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential of Mesenchymal Stromal Cells as Treatment for Severe Steroid-Refractory Acute Graft-Versus-Host Disease: A Critical Review of the Literature.
    Munneke JM; Spruit MJ; Cornelissen AS; van Hoeven V; Voermans C; Hazenberg MD
    Transplantation; 2016 Nov; 100(11):2309-2314. PubMed ID: 26714122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease.
    Sánchez-Guijo F; Caballero-Velázquez T; López-Villar O; Redondo A; Parody R; Martínez C; Olavarría E; Andreu E; Prósper F; Díez-Campelo M; Regidor C; Villaron E; López-Corral L; Caballero D; Cañizo MC; Pérez-Simon JA
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1580-5. PubMed ID: 24952358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study.
    Jurado M; De La Mata C; Ruiz-García A; López-Fernández E; Espinosa O; Remigia MJ; Moratalla L; Goterris R; García-Martín P; Ruiz-Cabello F; Garzón S; Pascual MJ; Espigado I; Solano C
    Cytotherapy; 2017 Aug; 19(8):927-936. PubMed ID: 28662983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients.
    Kurtzberg J; Prockop S; Teira P; Bittencourt H; Lewis V; Chan KW; Horn B; Yu L; Talano JA; Nemecek E; Mills CR; Chaudhury S
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):229-35. PubMed ID: 24216185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remestemcel-L: human mesenchymal stem cells as an emerging therapy for Crohn's disease.
    Mannon PJ
    Expert Opin Biol Ther; 2011 Sep; 11(9):1249-56. PubMed ID: 21787241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease.
    Ball LM; Bernardo ME; Roelofs H; van Tol MJ; Contoli B; Zwaginga JJ; Avanzini MA; Conforti A; Bertaina A; Giorgiani G; Jol-van der Zijde CM; Zecca M; Le Blanc K; Frassoni F; Egeler RM; Fibbe WE; Lankester AC; Locatelli F
    Br J Haematol; 2013 Nov; 163(4):501-9. PubMed ID: 23992039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remestemcel-L for acute graft-versus-host disease therapy.
    Chen GL; Paplham P; McCarthy PL
    Expert Opin Biol Ther; 2014 Feb; 14(2):261-9. PubMed ID: 24350681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mesenchymal stem cells for treatment of graft-versus-host disease].
    Najima Y
    Rinsho Ketsueki; 2017; 58(12):2440-2449. PubMed ID: 29332881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?
    Galipeau J
    Cytotherapy; 2013 Jan; 15(1):2-8. PubMed ID: 23260081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.